Dobutamine HCl

Dobutamine HCl (CAS No.: 49745-95-1) is a synthetic catecholamine and sympathomimetic small molecule primarily classified as an adrenergic receptor modulator for cardiovascular pharmacology and translational physiology research, with a functional profile characterized by preferential agonism at beta 1 adrenergic receptors and comparatively weaker activity at alpha 1 and beta 2 adrenergic receptors, making it a useful tool compound for dissecting receptor subtype dependent control of contractility related signaling; mechanistically, beta adrenergic receptor engagement is associated with Gs coupled activation of adenylyl cyclase, elevation of intracellular cyclic AMP, and downstream protein kinase A mediated phosphorylation events that regulate excitation contraction coupling and cellular functional output in relevant model systems, while mixed low level alpha and beta 2 components may contribute context dependent effects in certain assays; reported activity in research settings is generally described within nanomolar to micromolar concentration ranges depending on receptor system, assay format, and species background, and it is commonly employed in cell based studies of adrenergic signaling, ex vivo tissue preparations assessing inotropic responses, and animal model experiments focused on hemodynamic and cardiac performance phenotyping, as well as in pharmacological benchmarking and counter screening workflows where comparator agonists are required, with the concentrations or doses used in experiments typically depending on specific experimental designs and research objectives.